Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and gastrointestinal tolerance study of recombinant human lactoferrin in healthy volunteers
NL-OMON34362Active, not recruiting
- Sponsor
- Pharming Group
- Start
- Oct 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of lactoferrin (3 arms), sponsored by Pharming Group. Primary endpoints: Clinical laboratory safety and Gastrointestinal tolerance. Started Oct 2011; status: active, not recruiting.
02
Drugs
lactoferrin
Beyond the preview
Go deeper on NL-OMON34362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34362.